Earth Science Tech Inc (ETST) Return on Investment ROI from the second quarter of 2026 to second quarter of 2026 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Earth Science Tech Inc   (ETST)


Earth Science Tech Inc's ROI from its second quarter of 2026 to the second quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Earth Science Tech Inc's ROI in the second quarter of 2026?
Earth Science Tech Inc achieved a return on average invested assets (ROI) of 52.13 % in its second quarter of 2026, which is below Earth Science Tech Inc's average return on investment, which stands at 429.33%.

ROI fell compared to the first quarter of 2026, despite the net income growth of 16.16% from the first quarter of 2026.

Within the Healthcare sector 22 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 64, from total ROI ranking in the first quarter of 2026 at 73.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
II. Quarter		 (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter
Y / Y Investment Change TTM 66.89 % 70.99 % 66.74 % 62.09 % 52.5 %
Y / Y Net Income Change TTM 33.85 % 45.62 % 66.14 % 248.56 % 250.5 %
Investment (TTM) in Millions 8 8 7 6 5
Return On Investment (TTM) 52.13 % 59.72 % 63.13 % 70.99 % 65 %
ETST's Overall Ranking # 64 # 73 # 0 # #
Seq. Investment Change TTM 11.17 % 12.79 % 16.16 % 14.59 % 13.9 %
Seq. Net Income Change TTM -2.97 % 6.7 % 3.29 % 25.16 % 5.57 %
Net Income (TTM) in Millions 4 4 4 4 3

ETST Company Profile >> Back to ETST Roi Comparisons >> See Annual ETST Return On Investment



Return On Investment ETST's Ranking
Within: No.
Industry # 12
Sector # 23
Overall # 64

Return On Investment Statistics
High Average Low
5566.71 %
429.33 %
-1512.76 %
(Mar 31 2014)   (Jun 30 2023)







Financial Statements
Earth Science Tech Inc's II. Quarter Investments $ 8 Millions ETST's Balance sheet
Earth Science Tech Inc's II. Quarter Income $ 1 Millions Quarterly ETST's Income Statement
ETST's Income by Division See ETST's Income by Division


ETST Annual Return On Investment (Mar 31 2026)
2026		 (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2022)
2022
Total Investments in Millions 7 4 2 1 -2
Y / Y Investment Growth 82.12 % 68.09 % 62.59 % - -
Net Income in Millions 4 3 1 0 3
Y / Y Net Income Growth 10.67 % 300.63 % - - -
Annual Return On Investment 50.93 % 83.8 % 35.16 % -25.72 % -


Annual Roi Comment
In the fiscal year 2026 ROI deteriorated to 50.93 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ETST's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ETST's Competitors
Subscribers only: Roi for Earth Science Tech Inc's Suppliers
Subscribers only: Return On Investment for ETST's Customers

Other Ratios
ETST's Roa ETST's Inventory Turnover Ratio ETST's Growth Rates ETST's Dividend Statistics
ETST's Profitability Ratios ETST's Asset Turnover Ratio ETST's Dividend Growth
ETST's Roe ETST's Valuation Ratios ETST's Financial Strength Ratios ETST's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Arbutus Biopharma Corp  120.80 %
Indivior Pharmaceuticals Inc   108.22 %
Lensar Inc   94.32 %
Exelixis Inc   75.01 %
Ironwood Pharmaceuticals inc   68.68 %
Rigel Pharmaceuticals Inc  68.50 %
Alnylam Pharmaceuticals Inc   63.14 %
Idexx Laboratories Inc  52.51 %
Aurinia Pharmaceuticals Inc   45.04 %
Nurix Therapeutics Inc   44.12 %
Medpace Holdings Inc   41.14 %
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Protalix Biotherapeutics inc   26.06 %
Standard Biotools Inc   23.91 %
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %

Date modified: 2026-11-10T10:01:29+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.